2017-2022年儿科医疗器械研究特征与结果分析
该横断面分析纳入ClinicalTrials.gov上2017至2022年注册的482项儿科医疗器械干预性研究,多数为单中心、非随机、开放标签设计,仅21.8%的已完成研究在同行评议期刊发表结果。研究提示需优化试验设计并加强结果及时传播。
要点
- 84.2%研究评估II类器械,糖尿病相关器械最常见(11.8%)。
- 60.4%研究主要终点仅含有效性,无安全性终点。
- 已完成研究中51.6%样本量<50,仅21.8%结果已发表。
核心结论
- 儿科医疗器械研究以II类器械为主,设计严谨性不足且结果传播滞后。
研究设计与样本
- 对ClinicalTrials.gov上2017年1月1日至2022年12月12日注册的、评估FDA监管II或III类器械且入组≤17岁患者的干预性研究进行横断面分析。
主要发现
- 482项研究中,406项(84.2%)评估II类器械,76项(15.8%)评估III类器械。
- 最常见器械类型为糖尿病相关器械(57项,11.8%)和监测与测量设备(39项,8.1%)。
- 326项(67.6%)为单中心研究,255项(52.9%)为非随机设计,350项(72.6%)为开放标签设计。
- 278项(57.7%)由学术机构资助,142项(29.5%)由工业界资助。
- 291项(60.4%)主要终点仅含有效性而无安全性终点。
关键数值与推荐
- 已完成研究中,64项(51.6%)入组<50名参与者,88项(71.0%)入组<100名参与者。
- 中位随访3.0年后,27项(21.8%)已完成研究的结果可在同行评议出版物中获取。
临床怎么用
- 提示儿科医生关注医疗器械研究证据的局限性,如样本量小、非随机设计及结果发表延迟。
局限性
- 仅纳入ClinicalTrials.gov注册研究,可能遗漏未注册研究。
- 结果发表状态截至2022年12月27日,随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The development of medical devices for children faces unique challenges that have contributed to a paucity of devices specifically designed and tested for children. Increased knowledge on research activities for pediatric devices can guide optimal study design and ensure timely dissemination of clinical findings. METHODS: We performed a cross-sectional analysis of interventional studies registered on ClinicalTrials.gov, initiated January 1, 2017, through December 12, 2022, evaluating a Food and Drug Administration-regulated class II or III device, and enrolling any pediatric patients (aged ≤17 years). Data were extracted from ClinicalTrials.gov on study characteristics and from Devices@FDA on device features. For completed studies, we determined whether results were reported in a peer-reviewed publication as of December 27, 2022. RESULTS: Among 482 studies, 406 (84.2%) examined a class II device and 76 (15.8%) a class III device. The most common device types were diabetes-related devices (N = 57, 11.8%) and monitors and measurement devices (N = 39, 8.1%). Most studies were single-center (N = 326, 67.6%), used a nonrandomized (N = 255, 52.9%), open label (N = 350, 72.6%) design, and were funded by academic institutions (N = 278, 57.7%) or industry (N = 142, 29.5%). A total of 291 (60.4%) studies included a primary outcome of only efficacy without safety endpoints. Among completed studies, more than half (N = 64, 51.6%) enrolled <50 participants and 71.0% (N = 88) <100. After median follow-up of 3.0 years, results were available in publications for 27 (21.8%) completed studies. CONCLUSIONS: Our findings serve to inform programs and initiatives seeking to increase pediatric-specific device development. In addition to considerations on ensuring rigorous trial design, greater focus is needed on timely dissemination of results generated in pediatric device studies.
引用
- Quazi S, Narang C, Espinoza JC, et al. Characteristics and Results of Pediatric Medical Device Studies: 2017-2022. Pediatrics. 2023. PMID: 37565273. doi:10.1542/peds.2022-059842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。